Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students.
暂无分享,去创建一个
H. Balfour | K. Hogquist | H. Vezina | Beth D Mullan | D. Schmeling | J. Knight | Julie A Ed | W. Thomas | Oludare A. Odumade | O. Odumade | D. O. Schmeling | Beth D. Mullan
[1] H. Balfour,et al. Primary Epstein-Barr virus infection does not erode preexisting CD8+ T cell memory in humans , 2012, The Journal of experimental medicine.
[2] H. Balfour,et al. Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections , 2011, Clinical Microbiology Reviews.
[3] K. Fink,et al. Contribution of Herpesvirus Specific CD8 T Cells to Anti-Viral T Cell Response in Humans , 2010, PLoS pathogens.
[4] R. Welsh,et al. Heterologous immunity between viruses , 2010, Immunological reviews.
[5] D. Thorley-Lawson,et al. The Dynamics of EBV Shedding Implicate a Central Role for Epithelial Cells in Amplifying Viral Output , 2009, PLoS pathogens.
[6] J. Altman,et al. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. , 2008, Immunity.
[7] H. Balfour. Epstein-Barr virus vaccine for the prevention of infectious mononucleosis--and what else? , 2007, The Journal of infectious diseases.
[8] Abdul Salam Jarrah,et al. BIOINFORMATICS ORIGINAL PAPER doi:10.1093/bioinformatics/btm044 Systems biology Simulating Epstein-Barr virus infection with C-ImmSim , 2022 .
[9] A. Rickinson,et al. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. , 2007, Annual review of immunology.
[10] M. Melbye,et al. The epidemiology of EBV and its association with malignant disease , 2007 .
[11] Bernard Roizman,et al. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis , 2007 .
[12] A. Swerdlow,et al. A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] Richard C Brundage,et al. A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis. , 2005, The Journal of infectious diseases.
[14] A. Swerdlow,et al. The immune response to primary EBV infection: a role for natural killer cells , 2005, British journal of haematology.
[15] L. Meyer,et al. CD8+ T Cells Specific for EBV, Cytomegalovirus, and Influenza Virus Are Activated during Primary HIV Infection1 , 2004, The Journal of Immunology.
[16] S. L. Silins,et al. Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load. , 2001, Blood.
[17] J. Parkin,et al. A phase III study of recombinant human interferon gamma to prevent opportunistic infections in advanced HIV disease. , 2001, AIDS research and human retroviruses.
[18] G. Ogg,et al. Direct Visualization of Antigen-specific CD8+T Cells during the Primary Immune Response to Epstein-Barr Virus In Vivo , 1998, The Journal of experimental medicine.
[19] B. Griffin. Relation of Burkitt's tumor‐associated herpes‐type virus to infectious mononucleosis , 1998, Reviews in medical virology.
[20] L. Gissmann,et al. Subclinical Epstein-Barr virus infection of both the male and female genital tract--indication for sexual transmission. , 1992, The Journal of investigative dermatology.
[21] S. Lemon,et al. A SECOND SITE FOR EPSTEIN-BARR VIRUS SHEDDING: THE UTERINE CERVIX , 1986, The Lancet.
[22] H. Penman. NEOPLASIA AND NEOPLASMS , 1985, The Lancet.
[23] P. Levine,et al. Early primary infection and high Epstein‐barr virus antibody titers in greenland eskimos at high risk for nasopharyngeal carcinoma , 1984, International journal of cancer.
[24] N. Day,et al. Sero-epidemiology of the Epstein-Barr virus: preliminary analysis of an international study - a review. , 1975, IARC scientific publications.
[25] V. Diehl,et al. Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. , 1968, Proceedings of the National Academy of Sciences of the United States of America.
[26] W. Henle,et al. Immunofluorescence, interference, and complement fixation technics in the detection of the herpes-type virus in Burkitt tumor cell lines. , 1967, Cancer research.
[27] M. Epstein,et al. VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. , 1964, Lancet.